Tredje AP-fonden’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,996
Closed -$601K 387
2025
Q1
$601K Hold
3,996
0.01% 409
2024
Q4
$738K Sell
3,996
-3,996
-50% -$770K 0.01% 441
2024
Q3
$1.57M Hold
7,992
0.01% 406
2024
Q2
$1.65M Sell
7,992
-126
-2% -$28.6K 0.02% 384
2024
Q1
$2.2M Hold
8,118
0.02% 344
2023
Q4
$1.92M Sell
8,118
-330
-4% -$64.9K 0.02% 389
2023
Q3
$1.66M Sell
8,448
-790
-9% -$162K 0.02% 407
2023
Q2
$1.94M Sell
9,238
-1,550
-14% -$308K 0.03% 388
2023
Q1
$2.18M Buy
10,788
+505
+5% +$114K 0.03% 374
2022
Q4
$2.24M Sell
10,283
-3,468
-25% -$757K 0.04% 350
2022
Q3
$2.71M Buy
13,751
+10,371
+307% +$2.24M 0.06% 261
2022
Q2
$723K Hold
3,380
0.02% 310
2022
Q1
$960K Hold
3,380
0.02% 318
2021
Q4
$1.27M Buy
+3,380
New +$1.31M 0.02% 316

Other funds holding CRL

Tredje AP-fonden's CRL Position: Q2 2025 in Review

Tredje AP-fonden sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 3,996 shares — an estimated $601K sold.

Tredje AP-fonden first reported a position in CRL in Q4 2021 and held it in 14 quarters. The position peaked at $2.71M in Q3 2022. 518 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Tredje AP-fonden reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Tredje AP-fonden sold 3,996 Charles River Laboratories shares in Q2 2025, an estimated $601K.
  • Tredje AP-fonden first reported a position in Charles River Laboratories in Q4 2021 and held it in 14 quarters.
  • Tredje AP-fonden's Charles River Laboratories position peaked at $2.71M in Q3 2022.
  • 518 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Tredje AP-fonden's 13F filing for Q2 2025, filed 5 Aug 2025.